Tower Research Capital LLC (Trc) Adaptive Biotechnologies Corp Transaction History

Tower Research Capital LLC (Trc)

  • $4.87 Billion
  • Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 680 shares of ADPT stock, worth $5,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
680
Previous 15,791 95.69%
Holding current value
$5,548
Previous $80,000 95.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$4.37 - $6.78 $66,035 - $102,452
-15,111 Reduced 95.69%
680 $4,000
Q3 2024

Nov 14, 2024
BUY
$3.37 - $5.12 $4,128 - $6,272
1,225 Added 8.41%
15,791 $80,000
Q2 2024

Aug 13, 2024
BUY
$2.34 - $3.96 $31,318 - $53,000
13,384 Added 1132.32%
14,566 $52,000
Q1 2024

May 15, 2024
SELL
$2.88 - $4.8 $225,679 - $376,132
-78,361 Reduced 98.51%
1,182 $3,000
Q4 2023

Feb 13, 2024
BUY
$3.46 - $5.33 $240,231 - $370,067
69,431 Added 686.62%
79,543 $389,000
Q3 2023

Nov 14, 2023
SELL
$5.07 - $8.44 $16,644 - $27,708
-3,283 Reduced 24.51%
10,112 $55,000
Q2 2023

Aug 14, 2023
SELL
$6.19 - $8.78 $158,358 - $224,618
-25,583 Reduced 65.63%
13,395 $89,000
Q1 2023

May 09, 2023
BUY
$7.8 - $10.11 $297,398 - $385,474
38,128 Added 4485.65%
38,978 $344,000
Q4 2022

Feb 10, 2023
SELL
$6.26 - $9.34 $120,592 - $179,925
-19,264 Reduced 95.77%
850 $6,000
Q3 2022

Nov 10, 2022
BUY
$6.5 - $12.67 $106,398 - $207,395
16,369 Added 437.09%
20,114 $143,000
Q2 2022

Aug 15, 2022
SELL
$6.4 - $14.73 $109,408 - $251,809
-17,095 Reduced 82.03%
3,745 $30,000
Q1 2022

May 12, 2022
BUY
$10.12 - $28.9 $202,663 - $578,751
20,026 Added 2460.2%
20,840 $290,000
Q4 2021

Feb 14, 2022
SELL
$25.17 - $36.85 $14,095 - $20,636
-560 Reduced 40.76%
814 $23,000
Q3 2021

Nov 15, 2021
SELL
$30.02 - $39.87 $232,174 - $308,354
-7,734 Reduced 84.91%
1,374 $47,000
Q2 2021

Aug 16, 2021
BUY
$32.22 - $44.59 $246,450 - $341,068
7,649 Added 524.26%
9,108 $372,000
Q1 2021

May 17, 2021
SELL
$37.26 - $67.74 $163,981 - $298,123
-4,401 Reduced 75.1%
1,459 $59,000
Q4 2020

Feb 16, 2021
BUY
$45.01 - $65.47 $219,918 - $319,886
4,886 Added 501.64%
5,860 $347,000
Q3 2020

Nov 16, 2020
SELL
$35.79 - $48.81 $22,619 - $30,847
-632 Reduced 39.35%
974 $47,000
Q2 2020

Aug 13, 2020
BUY
$24.95 - $48.38 $40,069 - $77,698
1,606 New
1,606 $78,000
Q4 2019

Feb 07, 2020
SELL
$24.56 - $32.8 $1,326 - $1,771
-54 Closed
0 $0
Q3 2019

Nov 05, 2019
BUY
$30.31 - $53.51 $1,636 - $2,889
54 New
54 $2,000

Others Institutions Holding ADPT

# of Institutions
224
Shares Held
146M
Call Options Held
19.6K
Put Options Held
27.2K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.17B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email